Chammas & Marcheteau

Chammas & Marcheteau advised Kreaxi and UI Investissement on their participation in Cilkoa’s first round of financing. Cilkoa announced that it has successfully completed a seed...

Chammas & Marcheteau advised Yotta Capital Partners on its acquisition of a majority stake in SEDI-ATI. Yotta Capital Partners, the leading French investment fund dedicated to...

Chammas & Marcheteau advised Bpifrance, Quantonation, Supernova Invest and Innovacom on their participation in Quobly’s fundraising. Quobly, formerly known as Siquance, a company specialized in the...

For this operation, Gleamer was advised by the law firm McDermott Will & Emery AARPI and the investment bank Cambon Partners. Chammas & Marcheteau advised Supernova...

Chammas & Marcheteau advised Hoppen and its historical partners on the investment in its capital by Après-demain SA. Après-demain SA, the parent company of Debiopharm active...

Chammas & Marcheteau advised Ecov in its fundraising. Ecov has just completed a new round of fundraising. The carpooling mobility operator announced that it has raised the...

Fiducial Legal By Lamy, Deprez Guignot & Associés and Clipperton Finance advised the partners of Beastly on the sale. Biggie Group was advised by Coblence Avocats,...

Chammas & Marcheteau advised Epopée Gestion, via its fund Epopée West Web Valley II, in the context of their participation in this financing round. Joffe &...

Stephenson Harwood advised Creadev in this transaction. Requet Chabanel advised Nous Epiceries Anti-Gaspi. The historical investors were accompanied by the law firm Chammas & Marcheteau. D’Alverny...

Chammas & Marcheteau advised Sifflet in its Series A fundraising. The company Sifflet, specialized in monitoring and quality control of enterprise data, recently successfully raised €12...

Chammas & Marcheteau advised Shift4Good in its participation in this round of financing. Shift4Good, a venture capital fund manager specializing in impact investing in smart mobility and circular economy startups, has participated in...

Chammas & Marcheteau advised Kayentis on its fundraising. Kayentis, a French software solutions provider for pharmaceutical clinical trial management, has recently raised €5 million from its existing investors...